ONCAlert | 2018 SGO Annual Meeting on Women’s Cancer

Dr. Ramona Dadu on Immunotherapies and Their Role in Thyroid Cancer

Ramona Dadu, MD
Published Online: Feb 16,2016


Ramona Dadu, MD, endocrinologist, MD Anderson Cancer Center, discusses the benefits of using immunotherapies in thyroid cancer and some of the potential drawbacks that coincide with the treatments. Dadu says immunotherapies could afford patients with thyroid cancer an elongated progression free survival, potentially less toxicities, and most importantly an extensive overall survival benefit.

Dadu says some of the potential drawbacks and toxicities associated with immunotherapies, particularly in thyroid cancer, are neumonitis and diverticulitis. She adds that these toxicities could also be specifically related to the thyroid and result in such ailments as thyroiditis or hypophysitis.


Clinical Articles

Dr. Ramona Dadu on Immunotherapies and Their Role in Thyroid Cancer
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.